Institutional Ownership Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS). We have compiled data on the 194 institutions that hold shares in the stock, with a total of 118 Million shares, which have been reported (via 13F filing form) to have a value of $531 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Saba Capital Management, L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
678,771
shares
|
$3.07 Million
0.09% of portfolio
|
Q3 2025
Reduced 46.13%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
528,340
shares
|
$2.39 Million
0.0% of portfolio
|
Q3 2025
Added 5.78%
|
|
|
Quinn Opportunity Partners LLC
Charlottesville, VA |
Nov 13, 2025 Q3 2025 |
514,513
shares
|
$2.33 Million
0.18% of portfolio
|
Q3 2025
Added 10.76%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
514,083
shares
|
$2.32 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.29%
|
|
|
Western Standard LLC
Los Angeles, CA |
Nov 12, 2025 Q3 2025 |
507,853
shares
|
$2.3 Million
0.68% of portfolio
|
Q3 2025
New holding
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Nov 13, 2025 Q3 2025 |
505,099
shares
|
$2.28 Million
0.06% of portfolio
|
Q3 2025
Added 12.45%
|
|
|
Freestone Capital Holdings, LLC
Seattle, WA |
Nov 12, 2025 Q3 2025 |
442,500
shares
|
$2 Million
0.06% of portfolio
|
Q4 2024
Reduced 0.16%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
313,307
shares
|
$1.42 Million
0.0% of portfolio
|
Q2 2024
Added 6.51%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
310,051
shares
|
$1.4 Million
0.02% of portfolio
|
Q3 2025
Added 18.22%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
300,455
shares
|
$1.36 Million
0.0% of portfolio
|
Q3 2025
Added 34.86%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
284,330
shares
|
$1.29 Million
0.0% of portfolio
|
Q3 2025
Reduced 30.06%
|
|
|
Ledgewood Wealth Advisors, LLC
Exeter, NH |
Oct 23, 2025 Q3 2025 |
278,436
shares
|
$1.26 Million
0.75% of portfolio
|
Q4 2024
New holding
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 13, 2025 Q3 2025 |
276,300
shares
|
$1.25 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
257,934
shares
|
$1.17 Million
0.0% of portfolio
|
Q3 2025
Reduced 37.28%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
236,829
shares
|
$1.07 Million
0.0% of portfolio
|
Q2 2025
Added 329.25%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
215,041
shares
|
$971,985
0.0% of portfolio
|
Q3 2025
Reduced 41.57%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
211,784
shares
|
$957,263
0.0% of portfolio
|
Q3 2025
Added 1.91%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
209,638
shares
|
$947,563
0.0% of portfolio
|
Q3 2025
Added 15.77%
|
|
|
Stem Point Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
205,388
shares
|
$928,353
0.19% of portfolio
|
Q3 2025
New holding
|
|
|
Murchinson Ltd.
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
200,000
shares
|
$903,999
0.15% of portfolio
|
Q3 2025
New holding
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
197,838
shares
|
$894,227
0.0% of portfolio
|
Q3 2025
Reduced 13.91%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
193,691
shares
|
$875,483
0.0% of portfolio
|
Q3 2025
Added 61.04%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
189,952
shares
|
$858,583
0.0% of portfolio
|
Q3 2025
Added 366.71%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 13, 2025 Q3 2025 |
159,118
shares
|
$719,213
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
143,870
shares
|
$650,292
0.0% of portfolio
|
Q3 2025
Added 19.65%
|
|